Peritoneal Carcinomatosis

Oncology·MeSH: Carcinoma, Transitional Cell

5 drugs in development·2 companies·7 clinical trials

Drug Pipeline by Phase

Phase 2(2)

Drug	Company
Mitomycin C	ENANTA PHARMACEUTICALS INC (ENTA)
Sodium Fluoride F-18	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1(2)

Drug	Company
gl-onc1	GENELUX Corp (GNLX)
Sodium Chloride 0.9%	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 4(1)

Drug	Company
Sodium Thiosulfate	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 5 drugs in development for Peritoneal Carcinomatosis across 2 companies.

There are 7 clinical trials targeting Peritoneal Carcinomatosis tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.